Lehrer-Graiwer Joshua 4
4 · Global Blood Therapeutics, Inc. · Filed Mar 4, 2020
Insider Transaction Report
Form 4
Lehrer-Graiwer Joshua
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2020-03-01$63.96/sh−612$39,144→ 3,733 total - Exercise/Conversion
Common Stock
2020-03-01+1,750→ 4,345 total - Exercise/Conversion
Restricted Stock Units
2020-03-01−1,750→ 3,500 total→ Common Stock (1,750 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,750 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The shares of Common Stock underlying the RSUs shall vest in 8 equal semi-annual installments over 4 years from March 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.